Corbus Pharmaceuticals Holdings (CRBP) Current Assets (2013 - 2025)

Corbus Pharmaceuticals Holdings has reported Current Assets for 13 years, with the latest figure at $167.0 million in Q4 2025.

• On a quarterly basis, Current Assets rose 9.14% year-over-year to $167.0 million in Q4 2025; TTM through Dec 2025 was $167.0 million, a 9.14% increase from a year earlier, with the FY2025 full-year figure at $167.0 million, up 9.14% from the prior year.
• Current Assets was $167.0 million for Q4 2025 at Corbus Pharmaceuticals Holdings, up from $107.6 million in the prior quarter.
• The five-year high for Current Assets was $167.0 million in Q4 2025, with the low at $23.5 million in Q4 2023.
• Average Current Assets over 5 years is $100.1 million, with a median of $109.6 million recorded in 2021.
• The sharpest annual moves came in 2023 and 2024: Current Assets plunged 60.87% in 2023, then jumped 549.69% in 2024.
• Over 5 years, Current Assets stood at $100.2 million in 2021, then slumped by 39.94% to $60.2 million in 2022, then slumped by 60.87% to $23.5 million in 2023, then surged by 549.69% to $153.0 million in 2024, then advanced by 9.14% to $167.0 million in 2025.
• The last three Current Assets figures came in at $167.0 million (Q4 2025), $107.6 million (Q3 2025), and $122.8 million (Q2 2025), per Business Quant data.